Shoulder Innovations, Inc. (SI) stock
SINYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3049% above fair value
$20.31−0.34 (-1.65%)
Close on Nov 19, 2026Market cap $422.83MP/E –Yield –
Shoulder Innovations free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Shoulder Innovations's free cash flow for the twelve months ending Jun 30, 2026 was -$47.08M. For fiscal 2025 it was -$36.02M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$36.02M | – |
| FY2024 | Dec 31, 2024 | -$18.16M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$9.55M | – |
| Q1 FY2026 | Mar 31, 2026 | -$15.09M | – |
| Q4 FY2025 | Dec 31, 2025 | -$11.07M | – |
| Q3 FY2025 | Sep 30, 2025 | -$11.37M | – |
| Q2 FY2025 | Jun 30, 2025 | -$6.27M | – |
| Q1 FY2025 | Mar 31, 2025 | -$7.32M | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.32M | – |
| Q3 FY2024 | Sep 30, 2024 | -$5.78M | – |
See a number that looks wrong?